Adverum Biotechnlogies Inc (NASDAQ:ADVM)

Adverum Biotechnlogies Inc (NASDAQ:ADVM)

Share Price
$ 10.96
-0.44 (-3.86 %)
Market Cap
$699.04 m
Proactive Investors - Run By Investors For Investors

Adverum Biotechnlogies Inc

Adverum Biotechnologies Inc (ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases.

52-week High/Low: $12.10 / $2.62
Sector: MSN - Healthcare & pharmaceuticals
Market Cap: $699.04 m
col 3
col 4
col 5
col 6

Adverum Biotechnlogies Inc Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use